NUNZ OTC
Nunzia Pharmaceutical Company
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$87K
+99.0% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$87K
+99.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$131
+100.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$13K | -$19K | -$34K | -$9M | -$78M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $2K | $78M |
| Change in Working Capital | $13K | $27K | $30K | $14K | -$24K |
| Other Non-Cash Items | $0 | -$9K | $0 | $0 | $0 |
| Operating Cash Flow | $0 | $0 | -$4K | -$9M | -$87K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $23K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $4K | -$21K | $87K |
| Financing Cash Flow | $0 | $0 | $4K | $2K | $87K |
| Net Change in Cash | $0 | $0 | $0 | -$9M | $131 |
| Cash End of Period | $0 | $0 | $0 | -$9M | $131 |
| Free Cash Flow | $0 | $0 | -$4K | -$9M | -$87K |